Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Asset Utilization Ratio of 0.59 in Q1 2026, up 4.81% quarter-over-quarter from 0.57 in Q4 2025, and up 32.75% on a YoY basis from 0.45 in Q1 2025.
Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Pacira BioSciences' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.59 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 32.75% year-over-year to 0.59; the TTM figure through Mar 2026 stood at 0.59 (up 32.75% YoY), while the FY2025 annual figure was 0.52, up 15.01% from the prior year.
- Asset Utilization Ratio was 0.59 for Q1 2026 at Pacira BioSciences, up from 0.57 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.59 in Q1 2026 to a low of 0.01 in Q4 2022.
- Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.43 in 2024.
- Biggest YoY gain for Asset Utilization Ratio was 4760.21% in 2023; the steepest drop was 97.57% in 2023.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then jumped by 4760.21% to 0.43 in 2023, then climbed by 4.99% to 0.46 in 2024, then gained by 24.36% to 0.57 in 2025, then rose by 4.81% to 0.59 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.59 (Q1 2026), 0.57 (Q4 2025), and 0.51 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | Pacira BioSciences | 940.31 Mn | 738.13 Mn | 140.96 Mn | 0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.59 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 0.45 |
| Dec 31, 2024 | 0.46 |
| Sep 30, 2024 | 0.44 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.43 |
| Dec 31, 2023 | 0.43 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.34 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.38 |
| Jun 30, 2021 | 0.38 |